fashion -WSS

fashion

author：knowledge 2025-09-03 11:50:07 - browse：973

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： What the cancer research community can learn from the Covid response

WSS

Biotech investment managers search for lucrative opportunities

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

My superpower is killing ticks

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Diabetes management: Digital health tools fall short, study says

Microsoft strikes partnership with Duke Health to advance health AI

leisure time

fashion

explore

What does generative AI mean for health care? We asked experts

CRISPR technology availability, affordability needs to be expanded

In age of alternative facts, a scholarly course on calling out crap

ProMED, early warning system on disease outbreaks, in peril

United colonoscopy coverage change 'may cost lives,' doctors say

With Wegovy coverage, Medicare patients may face high costs

Novavax promises a turnaround & Lilly roils the obesity market

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

What does generative AI mean for health care? We asked experts

Stem cell clinics for heart failure: buyer be wary

Wikipedia

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Attacks on the drug industry will lead to fewer breakthroughs

This gene therapy has record $4.25 million price. It's saved children.

Erich Jarvis studies song birds to learn about human stuttering

Erich Jarvis studies song birds to learn about human stuttering

Erich Jarvis studies song birds to learn about human stuttering

leisure time

leisure time

Wikipedia

Wikipedia